Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy. FE [Internet]. 2021 Jun. 18 [cited 2025 Oct. 29];22(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1499